A study published in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can ...

ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...

King's College London researchers have created a unique collection of human stem cell models that could help to uncover why HIV leads to different outcomes in different people. The research was ...

Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and immunoediting compared with single-pathway CAR-T constructs. Complete tumor ...

Earlier-line bispecific therapy leverages lower disease refractoriness to drive deeper, more durable responses than typically ...

In MS trials, investigators are steering those cells toward B‑cell populations that appear to be driving inflammation.

A study published in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can overcome immune rejection in mice with humanized immune systems, surviving for ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...

Our immune system relies on T cells to fight infections. But T cells don't just show up and react—first, they train, get a ...

Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from Louisiana experts. "Maybe in 20 years," a doctor at LSU Health says. Here's ...